Lung cancer pill cuts risk of death by half, says ‘thrilling’ study

Taking the drug osimertinib once a day after surgery reduces chance of patients dying by 51%, trials show

A pill taken once a day cuts the risk of dying from lung cancer by half, according to “thrilling” and “unprecedented” results from a decade-long global study.

Taking the drug osimertinib after surgery dramatically reduced the risk of patients dying by 51%, results presented at the world’s largest cancer conference showed.